BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pre-Clinical Outsourcing

Samsung Bioepis Co., Ltd. And ATLATL Innovation Center Forge APAC Open Innovation Pact To Accelerate Early Stage Biotech Growth

Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as "ATLATL"), global innovation platform for life science research and deve...

April 29, 2026 | News

WuXi Biologics Advances Chengdu Microbial Manufacturing Site Toward GMP Production

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the structural completion and k...

April 27, 2026 | News

WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...

April 24, 2026 | News

Aragen Launches Women Led ChemiSHE Lab To Advance Leadership In Pharma R&D

Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) launched ChemiSHE, a first-of-its-kind chemistry synth...

April 17, 2026 | News

Thermo Fisher Scientific Launches Gibco CHOvantage GS Cell Line Development Kit To Accelerate Biologics Development

Gibco CHOvantage GS Cell Line Development Kit delivers high productivity, streamlined timelines and royalty-free, clinical-stage licensing options to suppo...

April 02, 2026 | News

NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development

NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"),...

April 02, 2026 | News

Yoshindo And Cytiva Strengthen Japan’s Biologics Sovereignty Through Scalable Modular Manufacturing

Strengthening Yoshindo’s domestic biosimilar manufacturing footprint Cytiva’s modular manufacturing platform to support Yoshindo wit...

March 25, 2026 | News

WuXi XDC Reports Strong 2025 Growth Driven By Bioconjugate Leadership And Expanding Global Footprint

Revenue increased by 46.7% YoY to RMB 5,944 million Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 3...

March 25, 2026 | Company results

SK Pharmteco Commits 100 Million Dollars To Strengthen Viral Vector Capabilities And Multi Modality CDMO Strategy

SK pharmteco announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term ...

March 20, 2026 | News

Pace Life Sciences Advances Digital Laboratory Operations With Labguru Platform Integration

Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U...

March 20, 2026 | News

Samsung Bioepis And Sandoz Expand Global Biosimilar Alliance Across Five Assets

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and ...

March 18, 2026 | News

BioCina Advances RLS 2201 With CMC Programme To Enable Clinical Entry

BioCina Pty Ltd., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC (Chemistry,...

March 18, 2026 | News

Sartorius Introduces Genetically Engineered CHO Host Cell Line To Boost Biomanufacturing Productivity

New genetically engineered CHO host cell line strengthens manufacturing efficiency Delivers up to two-fold higher protein expression, three-fold...

March 06, 2026 | News

AtomVie Supplies First Patient Dose In Radiopharm Theranostics Phase 1 2a Study Of 177Lu BetaBart

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first pat...

February 26, 2026 | News

Stay Connected